Bedford Group Transearch Expands Healthcare Advisory Board

January 20, 2021 – The healthcare advisory board of Bedford Group Transearch has expanded with the additions of Jamie Condie, former president of  Becton, Dickinson and Company USA and Canada; Cheryl MacDiarmid, senior vice president and head of global commercial strategy at ViiV Healthcare; Vafa Jamali, chief commercial officer at Rockley Photonics; and Simon Pedder, chief business and strategy officer of Athenex. The board will play a strategic role in helping the search firm support the leadership needs of its healthcare clients.

“We are both excited and honored to have Jamie, Cheryl, Vafa and Simon join our healthcare advisory board,” said Howard Pezim, managing director of Bedford Group Transearch’s North American healthcare practice. Their combined exceptional industry knowledge, breadth and depth of insight will be invaluable in supporting our clients.”

“The world and the healthcare landscape has seen exponential change as a result of the economic and social impacts of the COVID-19 crisis” said Darren Raycroft, Bedford Group Transearch North American healthcare practice leader. “The formation of this advisory board will help us to better understand and anticipate the needs of our North American healthcare clients during this transformational time.”

Most recently, the president of Becton Dickinson (BD) for the U.S. and Canada regions, Mr. Condie oversaw an organization of 6,000-plus employees during a period of organic and acquisition led growth for BD worldwide. Since joining BD in 2013, he held the country president role in Canada as well as global business unit leadership roles based in the U.S. Mr. Condie spent the early part of his career within the consumer products and nutraceutical space with Clairol, PepsiCo, Unilever and Jamieson Laboratories in a variety of marketing and sales leadership roles.

Ms. MacDiarmid is a member of the ViiV Healthcare executive team, a global pharmaceutical company. She is responsible for setting strategy with a wave of transformative medicines and digital services. In prior large business unit leadership roles with GSK in the U.S. and Canada over 20 years, Ms. MacDiarmid has expertise is in building and leading teams that deliver performance pivots in both pharmaceuticals and vaccines.

Mr. Jamali is the chief commercial officer for Rockley Photonics, an integrated optics solutions provider, focused on bringing novel and disruptive sensing and patient monitoring capabilities from the lab to the home via consumer wearables. Prior to this, he served as SVP and president of respiratory, gastrointestinal and informatics (RGI) at Medtronic. Mr. Jamali currently serves on the board of directors for Baylis Medical and Eptam Precision. His career has spanned sales, marketing and general management roles in the pharmaceutical, medical device, distribution and healthtech space with organizations such as Searle, Baxter, Cardinal Health and Covidien.

Currently chief business and strategy officer with Athenex, Dr. Pedder’s career spans big pharma and the biotech industry in drug development, including recent leadership roles as president and CEO of Cellectar Biosciences, president and CEO of Chelsea Therapeutics and VP of oncology pharma business at Hoffman-LaRoche. Formerly, he was a faculty in the department of pharmacology within the College of Medicine at the University of Saskatchewan.

Serving North America

With North American healthcare offices based in Toronto, Canada and Cambridge, MA, the Bedford Group is one of Canada’s largest privately-held executive search and talent advisory firms. Its services span the spectrum of talent management, including leadership assessment, coaching and development, and compensation advisory, as well as executive, managerial and senior technical recruitment. Established in 1979, the Bedford Group has three offices in Canada: Toronto, Oakville (Ontario) and Vancouver, all of which consult with clients throughout North America and globally.

Naomi Titleman Colla, the founder of Collaborativity, a consultancy focused on driving progressive talent strategy to improve collaboration, productivity and performance, recently joined the strategic advisory board of Bedford Group. Ms. Titleman Colla brings 20 years of professional experience and is a recognized authority on the new world of work, women in leadership, the gig economy and employee experience. In addition to Collaborativity, she is the co-founder of future foHRward, a leading-edge platform for the HR community. “Naomi has an impeccable track record collaborating with senior executives and boards of directors to develop and implement creative strategies that maximize employee engagement and drive business impact,” said Steven Pezim, managing director of Bedford Group.

Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; and Stephen Sawicki, Managing Editor – Hunt Scanlon Media

Share This Article


Notify of
Inline Feedbacks
View all comments